H20-HEALTH-Health, demographic change and wellbeing
Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola
The objective of this specific grant agreement (SGA) is to leverage co-funding from the European Commission to accelerate the development of vaccines against Rift Valley Fever (RVF), Chikungunya (CHIK) and Ebola virus diseases (EVD). • RVF and CHIK vaccine development will be addressed by CEPI’...
